Get the latest news on Aurora Spine stock with updates on market trends, financials, and analysis from Benzinga. Stay informed on ASAPF performance

Latest Aurora Spine Stock News | OTC:ASAPF | Benzinga

Aurora Spine Corp is engaged in the business of the development and commercialization of minimally invasive interspinous fusion systems and devices. The product portfolio includes implants, surgical tools, and biologics. It derives revenues primarily from the sale of spinal surgery implants, consumable products used in spinal surgeries, and service revenue for referring products to its customers.

Aurora Spine Corp

Press Releases

Aurora Spine Corporation Announces Participation at the North American Spine Society Annual Meeting

Aurora Spine Corporation Announces Release of its Hydra Osteo Onyx Lumbar System

Aurora Spine Corporation Announces Third Quarter 2024 Financial Results

Aurora Spine Corporation Schedules Conference Call to Update Investors and Discuss Third Quarter Fiscal Year 2024 Financial Results

Aurora Spine Announces Leadership Promotions: Matt Paxton, Executive Vice President of Sales and Katelyn Sims, Area Vice President of Commercialization and Key Accounts

Aurora Spine Corporation Announces Completion of Enrollment in Groundbreaking REFINE Study: First Prospective, Multi-Center, Multi-Specialty Study on Lumbar Interlaminar Fusion

Aurora Spine to Attend the American Academy of Orthopaedic Surgeons Annual Meeting

Aurora Spine Announces FDA 510(k) Clearance for the AERO™ Facet Fusion System

Aurora Spine Announces Publication of Biomechanical Study Demonstrating Superiority of SiLO TFX™ Sacroiliac Fusion System

Aurora Spine Announces the Resignation of Board Director James Snow

ASAPF

TSXV:ASG

Aurora Spine

Comments

Aurora Spine Stock News

News

Latest Aurora Spine Stock News | OTC:ASAPF | Benzinga

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga